TagsNeurology 
AQUIPTA®

AQUIPTA® (Atogepant) ABBVIE HK Reg. No. HK-68287 (03 Jul, 2024) & HK-68288 (03 Jul, 2024) Composition: 1 Aquipta® (Atogepant) is an orally administered, small molecule, selective calcitonin gene-related peptide (CGRP) receptor antagonist...

Oct 22, 2024
LEQEMBI®

LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...

Aug 20, 2024
A New Chapter of Giant Cell Arteritis Treatment with Upadacitinib

Giant cell arteritis (GCA), also known as temporal arteritis is a chronic inflammatory vasculitis that predominately affects large- and medium-sized arteries in individuals above the age of 50. More notably, GCA affects the cranial branches of the c...

Aug 20, 2024
Deconstructing Early-onset Dementias

The Sheer Scale of the Problem While dementia is usually regarded as a disorder of old age, it can invariably also affect younger individuals under the age of 65 1 . Early-onset dementia (EOD), also known as young-onset dementia (YOD), is defined as...

Feb 7, 2024
Which Migraine Prophylaxis Both Works Well and May Save Your Wallet

Migraine as the second most disabling disease contributes to significant prevalence at 18% in women and 9% in men. Despite maybe 4 out of 10 migraine patients could potentially benefit from migraine preventive medicines, but the utilization of and a...

Dec 18, 2023
Age-related Cognitive Deline Preventable with Mediterranean Diet

Mediterranean diet (MD) has gained renowned reputation for its benefits to metabolic health, especially reducing the risk of cardiovascular events. The diet features an unambiguous combination of nutrients that encourages higher intake of dietary fi...

Dec 18, 2023
Where is the Sandman? A Review on the Clinical Challenges of Insomnia Disorder

Insomnia disorder is a prevalent condition that affects millions globally (perhaps including you!) While often being overlooked, insomnia disorder is characterised by difficulty initiating or maintaining sleep over a sustained period. Apart from sle...

Dec 18, 2023
The Unseen Challenges of Drug-Resistant Epilepsy

The Burden and Unmet Needs in Epileptic Sufferers EEpilepsy is one of the most common neurological conditions, with a prevalence of 0.5% to 1% 1 . It is considered a chronic brain disorder that affects people of all ages without geographical, social...

Oct 26, 2023
Revolutionising Migraine Treatment with Anti-CGRP Antibody – From Science to Clinical Practice

Migraine remains the second among the world's leading causes of disability and first among young females.1 Migraine attacks significantly impair a patient's quality of life and contribute to substantial economic burdens. In this regard, prev...

Aug 11, 2023
Vyepti

Vyepti ® ( Eptinezumab ) 6-7 Lundbeck Eptinezumab is a recombinant humanized monoclonal antibody that selectively inhibits calcitonin generelated peptide (CGRP) Compositio n : Available as a 100 mg/1mL concentrated solution for infusion Indica...

Jun 13, 2023
Always-available Psychotherapy for Depression and Anxiety by AI

Shortage of healthcare manpower is a common issue faced by many societies, including mental health professionals. It affects the access to relevant services and taxes on the cost for utilization as a result. Digital mental health applications are th...

Jun 13, 2023
Maintain Physically Active After Stroke for Better Recovery

The health benefits of physical activity are undeniable, especially in reducing the risk of cardiovascular diseases and various cancers. More than the prevention of ill health, being physical active indeed promotes better functional capacity and rec...

Jun 13, 2023